Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose intraoperative esketamine for postoperative recovery after ambulatory laparoscopic cholecystectomy
ChiCTR2600117446Phase 4Not yet recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain and Delayed postoperative recovery (DPR) (2 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoint: Total QoR-15 score on postoperative day 1. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postoperative painDelayed postoperative recovery (DPR)
Beyond the preview
Go deeper on ChiCTR2600117446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117446.